Management of Tardive Dyskinesia and Comorbidities
Panelists discuss how managing tardive dyskinesia in patients with comorbid mental health conditions requires a delicate balance between treating TD symptoms while maintaining psychiatric stability, emphasizing the importance of coordinated care between psychiatrists and movement disorder specialists to optimize medication regimens, monitor for potential drug interactions, and address the complex interplay between physical symptoms and psychological well-being.
Video series above is prompted by the following:
- How does the burden of comorbid conditions, such as mental health disorders, influence the management and outcomes of patients with TD?
- How does the long-term management of TD align with treatment strategies for other movement disorders, and what challenges or opportunities arise when managing coexisting conditions
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Encouraging Successful Completion of the Shingles Vaccine Series
September 16th 2025
- A Pharmacist’s View of Emerging CML Treatment
September 4th 2025
- Potential for Precision: Exploring Targeted Therapies in mCRC Care
September 4th 2025
- Empowering Pharmacists in the Management of Patients With Urothelial Cancer
September 3rd 2025
- Empowering Pharmacists in the Management of Patients With Urothelial Cancer
September 1st 2025